Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice

Elizabeth H. Sinz, Patrick M. Kochanek, C. Edward Dixon, Robert S B Clark, Joseph A. Carcillo, Joanne K. Schiding, Minzhi Chen, Stephen R. Wisniewski, Timothy M. Carlos, Debra Williams, Steven T. DeKosky, Simon C. Watkins, Donald W. Marion, Timothy R. Billiar

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Nitric oxide (NO) derived from the inducible isoform of NO synthase (iNOS) is an inflammatory product implicated both in secondary damage and in recovery from brain injury. To address the role of iNOS in experimental traumatic brain injury (TBI), we used 2 paradigms in 2 species. In a model of controlled cortical impact (CCI) with secondary hypoxemia, rats were treated with vehicle or with 1 of 2 iNOS inhibitors (aminoguanidine and L-N- iminoethyl-lysine), administered by Alzet pump for 5 days and 1.5 days after injury, respectively. In a model of CCI, knockout mice lacking the iNOS gene (iNOS(-/-)) were compared with wild-type (iNOS(+/+)) mice. Functional outcome (motor and cognitive) during the first 20 days after injury, and histopathology at 21 days, were assessed in both studies. Treatment of rats with either of the iNOS inhibitors after TBI significantly exacerbated deficits in cognitive performance, as assessed by Morris water maze (MWM) and increased neuron loss in vulnerable regions (CA3 and CA1) of hippocampus. Uninjured iNOS+/+ and iNOS(-/-) mice performed equally well in both motor and cognitive tasks. However, after TBI, iNOS(-/-) mice showed markedly worse performance in the MWM task than iNOS+/+ mice. A beneficial role for iNOS in TBI is supported.

Original languageEnglish (US)
Pages (from-to)647-656
Number of pages10
JournalJournal of Clinical Investigation
Volume104
Issue number5
DOIs
StatePublished - Sep 1999

Fingerprint

Neuroprotective Agents
Nitric Oxide Synthase Type II
Nitric Oxide Synthase
Protein Isoforms
Traumatic Brain Injury
Water
Wounds and Injuries
Knockout Mice
Brain Injuries
Lysine
Hippocampus
Nitric Oxide
Neurons

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Sinz, E. H., Kochanek, P. M., Dixon, C. E., Clark, R. S. B., Carcillo, J. A., Schiding, J. K., ... Billiar, T. R. (1999). Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. Journal of Clinical Investigation, 104(5), 647-656. https://doi.org/10.1172/JCI6670
Sinz, Elizabeth H. ; Kochanek, Patrick M. ; Dixon, C. Edward ; Clark, Robert S B ; Carcillo, Joseph A. ; Schiding, Joanne K. ; Chen, Minzhi ; Wisniewski, Stephen R. ; Carlos, Timothy M. ; Williams, Debra ; DeKosky, Steven T. ; Watkins, Simon C. ; Marion, Donald W. ; Billiar, Timothy R. / Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. In: Journal of Clinical Investigation. 1999 ; Vol. 104, No. 5. pp. 647-656.
@article{7e71f69aa133484dbd5d719268a58bec,
title = "Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice",
abstract = "Nitric oxide (NO) derived from the inducible isoform of NO synthase (iNOS) is an inflammatory product implicated both in secondary damage and in recovery from brain injury. To address the role of iNOS in experimental traumatic brain injury (TBI), we used 2 paradigms in 2 species. In a model of controlled cortical impact (CCI) with secondary hypoxemia, rats were treated with vehicle or with 1 of 2 iNOS inhibitors (aminoguanidine and L-N- iminoethyl-lysine), administered by Alzet pump for 5 days and 1.5 days after injury, respectively. In a model of CCI, knockout mice lacking the iNOS gene (iNOS(-/-)) were compared with wild-type (iNOS(+/+)) mice. Functional outcome (motor and cognitive) during the first 20 days after injury, and histopathology at 21 days, were assessed in both studies. Treatment of rats with either of the iNOS inhibitors after TBI significantly exacerbated deficits in cognitive performance, as assessed by Morris water maze (MWM) and increased neuron loss in vulnerable regions (CA3 and CA1) of hippocampus. Uninjured iNOS+/+ and iNOS(-/-) mice performed equally well in both motor and cognitive tasks. However, after TBI, iNOS(-/-) mice showed markedly worse performance in the MWM task than iNOS+/+ mice. A beneficial role for iNOS in TBI is supported.",
author = "Sinz, {Elizabeth H.} and Kochanek, {Patrick M.} and Dixon, {C. Edward} and Clark, {Robert S B} and Carcillo, {Joseph A.} and Schiding, {Joanne K.} and Minzhi Chen and Wisniewski, {Stephen R.} and Carlos, {Timothy M.} and Debra Williams and DeKosky, {Steven T.} and Watkins, {Simon C.} and Marion, {Donald W.} and Billiar, {Timothy R.}",
year = "1999",
month = "9",
doi = "10.1172/JCI6670",
language = "English (US)",
volume = "104",
pages = "647--656",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

Sinz, EH, Kochanek, PM, Dixon, CE, Clark, RSB, Carcillo, JA, Schiding, JK, Chen, M, Wisniewski, SR, Carlos, TM, Williams, D, DeKosky, ST, Watkins, SC, Marion, DW & Billiar, TR 1999, 'Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice', Journal of Clinical Investigation, vol. 104, no. 5, pp. 647-656. https://doi.org/10.1172/JCI6670

Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. / Sinz, Elizabeth H.; Kochanek, Patrick M.; Dixon, C. Edward; Clark, Robert S B; Carcillo, Joseph A.; Schiding, Joanne K.; Chen, Minzhi; Wisniewski, Stephen R.; Carlos, Timothy M.; Williams, Debra; DeKosky, Steven T.; Watkins, Simon C.; Marion, Donald W.; Billiar, Timothy R.

In: Journal of Clinical Investigation, Vol. 104, No. 5, 09.1999, p. 647-656.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice

AU - Sinz, Elizabeth H.

AU - Kochanek, Patrick M.

AU - Dixon, C. Edward

AU - Clark, Robert S B

AU - Carcillo, Joseph A.

AU - Schiding, Joanne K.

AU - Chen, Minzhi

AU - Wisniewski, Stephen R.

AU - Carlos, Timothy M.

AU - Williams, Debra

AU - DeKosky, Steven T.

AU - Watkins, Simon C.

AU - Marion, Donald W.

AU - Billiar, Timothy R.

PY - 1999/9

Y1 - 1999/9

N2 - Nitric oxide (NO) derived from the inducible isoform of NO synthase (iNOS) is an inflammatory product implicated both in secondary damage and in recovery from brain injury. To address the role of iNOS in experimental traumatic brain injury (TBI), we used 2 paradigms in 2 species. In a model of controlled cortical impact (CCI) with secondary hypoxemia, rats were treated with vehicle or with 1 of 2 iNOS inhibitors (aminoguanidine and L-N- iminoethyl-lysine), administered by Alzet pump for 5 days and 1.5 days after injury, respectively. In a model of CCI, knockout mice lacking the iNOS gene (iNOS(-/-)) were compared with wild-type (iNOS(+/+)) mice. Functional outcome (motor and cognitive) during the first 20 days after injury, and histopathology at 21 days, were assessed in both studies. Treatment of rats with either of the iNOS inhibitors after TBI significantly exacerbated deficits in cognitive performance, as assessed by Morris water maze (MWM) and increased neuron loss in vulnerable regions (CA3 and CA1) of hippocampus. Uninjured iNOS+/+ and iNOS(-/-) mice performed equally well in both motor and cognitive tasks. However, after TBI, iNOS(-/-) mice showed markedly worse performance in the MWM task than iNOS+/+ mice. A beneficial role for iNOS in TBI is supported.

AB - Nitric oxide (NO) derived from the inducible isoform of NO synthase (iNOS) is an inflammatory product implicated both in secondary damage and in recovery from brain injury. To address the role of iNOS in experimental traumatic brain injury (TBI), we used 2 paradigms in 2 species. In a model of controlled cortical impact (CCI) with secondary hypoxemia, rats were treated with vehicle or with 1 of 2 iNOS inhibitors (aminoguanidine and L-N- iminoethyl-lysine), administered by Alzet pump for 5 days and 1.5 days after injury, respectively. In a model of CCI, knockout mice lacking the iNOS gene (iNOS(-/-)) were compared with wild-type (iNOS(+/+)) mice. Functional outcome (motor and cognitive) during the first 20 days after injury, and histopathology at 21 days, were assessed in both studies. Treatment of rats with either of the iNOS inhibitors after TBI significantly exacerbated deficits in cognitive performance, as assessed by Morris water maze (MWM) and increased neuron loss in vulnerable regions (CA3 and CA1) of hippocampus. Uninjured iNOS+/+ and iNOS(-/-) mice performed equally well in both motor and cognitive tasks. However, after TBI, iNOS(-/-) mice showed markedly worse performance in the MWM task than iNOS+/+ mice. A beneficial role for iNOS in TBI is supported.

UR - http://www.scopus.com/inward/record.url?scp=0032728075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032728075&partnerID=8YFLogxK

U2 - 10.1172/JCI6670

DO - 10.1172/JCI6670

M3 - Article

C2 - 10487779

AN - SCOPUS:0032728075

VL - 104

SP - 647

EP - 656

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -